Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine E Dillon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|March 17, 2012
Pediatric and young adult patients and oncofertilityKatherine E Dillon, Clarisa R Gracia
Seminars in Reproductive Medicine|October 9, 2013
What is normal ovarian reserve?Katherine E Dillon, Clarisa R Gracia
Human Reproduction (Oxford, England)|August 14, 2012
Sperm and oocyte cryopreservation: comprehensive consent and the protection of patient autonomyKatherine E Dillon, Autumn M Fiester
Pediatric Blood & Cancer|September 17, 2013
Pregnancy after cancer: results from a prospective cohort study of cancer survivorsKatherine E Dillon, Mary D Sammel, Jill P Ginsberg, et al.
Fertility and Sterility|June 18, 2014
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraceptionLauren N C Johnson, Mary D Sammel, Katherine E Dillon, et al.
Fertility and Sterility|July 17, 2012
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicityKatherine E Dillon, Vasileios D Sioulas, Mary D Sammel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 25, 2013
Quality of life in female cancer survivors: is it related to ovarian reserve?Laxmi A Kondapalli, Katherine E Dillon, Mary D Sammel, et al.
Fertility and Sterility|October 23, 2012
Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapyKatherine E Dillon, Mary D Sammel, Maureen Prewitt, et al.
Reproductive Biomedicine Online|February 19, 2013
Response to ovarian stimulation in patients facing gonadotoxic therapyLauren N C Johnson, Katherine E Dillon, Mary D Sammel, et al.
Emerging Infectious Diseases|September 30, 2010
Imported Lassa fever, Pennsylvania, USA, 2010Valerianna Amorosa, Adam MacNeil, Ryan McConnell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|March 17, 2012
Pediatric and young adult patients and oncofertilityKatherine E Dillon, Clarisa R Gracia
Seminars in Reproductive Medicine|October 9, 2013
What is normal ovarian reserve?Katherine E Dillon, Clarisa R Gracia
Human Reproduction (Oxford, England)|August 14, 2012
Sperm and oocyte cryopreservation: comprehensive consent and the protection of patient autonomyKatherine E Dillon, Autumn M Fiester
Pediatric Blood & Cancer|September 17, 2013
Pregnancy after cancer: results from a prospective cohort study of cancer survivorsKatherine E Dillon, Mary D Sammel, Jill P Ginsberg, et al.
Fertility and Sterility|June 18, 2014
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraceptionLauren N C Johnson, Mary D Sammel, Katherine E Dillon, et al.
Fertility and Sterility|July 17, 2012
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicityKatherine E Dillon, Vasileios D Sioulas, Mary D Sammel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 25, 2013
Quality of life in female cancer survivors: is it related to ovarian reserve?Laxmi A Kondapalli, Katherine E Dillon, Mary D Sammel, et al.
Fertility and Sterility|October 23, 2012
Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapyKatherine E Dillon, Mary D Sammel, Maureen Prewitt, et al.
Reproductive Biomedicine Online|February 19, 2013
Response to ovarian stimulation in patients facing gonadotoxic therapyLauren N C Johnson, Katherine E Dillon, Mary D Sammel, et al.
Emerging Infectious Diseases|September 30, 2010
Imported Lassa fever, Pennsylvania, USA, 2010Valerianna Amorosa, Adam MacNeil, Ryan McConnell, et al.
Pageof 1